SoftOx Solutions AS (OSE: SOFTOX-ME), is developing antimicrobial products that
do not contain classical antibiotics or induce microbial resistance. This
technology is attractive for use in infection prevention and control procedures
to prevent spread of pathogens potential to cause Hospital Acquired Infection.  

After signing Letter of Intent between SoftOx Solutions AS and Antibac AS, both
companies have entered into exclusive negotiations for developing and
distributing the SoftOx technology within the market segments of disinfection in
the Scandinavian markets including Norway, Sweden and Denmark.

SoftOx and Antibac aim to develop and launch a new disinfection platform to
increase complience and improve the hand health of health care workers, who
currently report the highest incidence of irritated and damage skin among all
occupational groups.
The parties will conduct exclusive negotiations until December 1st, 2018.